News analysis: Brexit planning, budget battles and the role of multinational companies are among the key issues that will dominate Brussels agendas over the next year
Viewpoint: BioMed Alliance Director Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments. In Framework Programme 9, processes must be optimised and the budget boosted - to deliver for patients and the economy
In an interview with Science|Business, Director-General Robert-Jan Smits looks forward to greater synergies for research among EU policy areas, from agriculture to development
As of January 1st, 2018 Finpro – the Finnish trade promotion organization – and Tekes – the Finnish Funding Agency for Innovation – will unite as Business Finland.
Midlands Innovation, a group of eight universities including the University of Birmingham, has launched its plan for collaboration in technology transfer. The announcement was made at an event held at The Shard, London.
As Estonia’s EU presidency draws to a close, the country’s education and research minister Mailis Reps talks to Science|Business about the hurdles to negotiating a bigger EU research programme and the need to rationalise the funding landscape
Full membership is restored, but the Swiss are still counting the cost of being outside the EU research fold during the 2014 - 2016 immigration dispute. “If you’ve been there, you know how much it hurts,” says one scientist affected by the ban
French President Emmanuel Macron has proposed the creation of a European innovation body modelled on Darpa. Researchers at the Jacques Delors Institut in Berlin explore the agency’s potential structure and remit
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.